Cargando…
Zinc oxide nanoparticles conjugated with clinically-approved medicines as potential antibacterial molecules
At present, antibiotic resistance is one of the most pressing issues in healthcare globally. The development of new medicine for clinical applications is significantly less than the emergence of multiple drug-resistant bacteria, thus modification of existing medicines is a useful avenue. Among sever...
Autores principales: | Akbar, Noor, Aslam, Zara, Siddiqui, Ruqaiyyah, Shah, Muhammad Raza, Khan, Naveed Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272778/ https://www.ncbi.nlm.nih.gov/pubmed/34245385 http://dx.doi.org/10.1186/s13568-021-01261-1 |
Ejemplares similares
-
Silver Nanoparticle Conjugation-Enhanced Antibacterial Efficacy of Clinically Approved Drugs Cephradine and Vildagliptin
por: Masri, Abdulkader, et al.
Publicado: (2018) -
Antiamoebic Properties of Ceftriaxone and Zinc-Oxide–Cyclodextrin-Conjugated Ceftriaxone
por: Makhlouf, Zinb, et al.
Publicado: (2022) -
Zinc Oxide Nanoconjugates against Brain-Eating Amoebae
por: Siddiqui, Ruqaiyyah, et al.
Publicado: (2022) -
Moxifloxacin and Sulfamethoxazole-Based Nanocarriers Exhibit Potent Antibacterial Activities
por: Akbar, Noor, et al.
Publicado: (2021) -
Hesperidin-, Curcumin-, and Amphotericin B- Based Nano-Formulations as Potential Antibacterials
por: Akbar, Noor, et al.
Publicado: (2022)